Theriva Biologics, Inc. - Common stock (TOVX)
CUSIP: 87164U508
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common stock
- Shares outstanding
- 9,600,143
- Total 13F shares
- 437,052
- Share change
- +146,040
- Total reported value
- $177,030
- Price per share
- $0.41
- Number of holders
- 18
- Value change
- +$57,424
- Number of buys
- 11
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 87164U508?
CUSIP 87164U508 identifies TOVX - Theriva Biologics, Inc. - Common stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 87164U508:
Top shareholders of TOVX - Theriva Biologics, Inc. - Common stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| CVI Investments, Inc. |
13D/G
|
— |
4.9%
|
146,136
|
$206,052 | $0 | 31 Dec 2024 | |
| Empery Asset Management, LP |
13D/G
|
— |
5%
|
504,091
|
$201,636 | -$179,638 | 30 Sep 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.3%
|
120,031
|
$52,070 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.38%
|
36,018
|
$15,625 | — | 30 Jun 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.37%
|
35,601
|
$15,444 | — | 30 Jun 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.36%
|
34,495
|
$15,000 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
18,601
|
$8,069 | — | 30 Jun 2025 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.19%
|
17,818
|
$7,729 | — | 30 Jun 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.18%
|
17,187
|
$7,456 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.08%
|
7,568
|
$3,283 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
0.03%
|
3,000
|
$1,301 | — | 30 Jun 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
444
|
$190 | — | 30 Jun 2025 | |
| CLEAR STREET LLC |
13F
|
Company |
0%
|
100
|
$43 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
74
|
$32 | — | 30 Jun 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
60
|
$26 | — | 30 Jun 2025 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
11
|
$5 | — | 30 Jun 2025 | |
| Pandora Wealth, Inc. |
13F
|
Company |
0%
|
4
|
$2 | — | 30 Jun 2025 | |
| Francis Tufaro |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
100,000
|
— | — | 15 Dec 2022 |
Institutional Holders of Theriva Biologics, Inc. - Common stock (TOVX) as of Q3 2025
As of 30 Sep 2025,
Theriva Biologics, Inc. - Common stock (TOVX) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
437,052 shares.
The largest 10 holders included
Ikarian Capital, LLC, TWO SIGMA INVESTMENTS, LP, Virtu Financial LLC, JANE STREET GROUP, LLC, BOOTHBAY FUND MANAGEMENT, LLC, XTX Topco Ltd, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA ADVISERS, LP, UBS Group AG, and VANGUARD GROUP INC.
This page lists
18
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
15
Q3 2025 holders
18
Holder diff
3
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.